| Literature DB >> 32013227 |
Benjamin D Menze1,2, Mersimine F Kouamo2,3, Murielle J Wondji1,2, Williams Tchapga2, Micareme Tchoupo2, Michael O Kusimo2, Chouaibou S Mouhamadou4, Jacob M Riveron5, Charles S Wondji1,2.
Abstract
Growing insecticide resistance in malaria vectors is threatening the effectiveness of insecticide-based interventions, including Long Lasting Insecticidal Nets (LLINs). However, the impact of metabolic resistance on the effectiveness of these tools remains poorly characterized. Using experimental hut trials and genotyping of a glutathione S-transferase resistance marker (L119F-GSTe2), we established that GST-mediated resistance is reducing the efficacy of LLINs against Anopheles funestus. Hut trials performed in Cameroon revealed that Piperonyl butoxide (PBO)-based nets induced a significantly higher mortality against pyrethroid resistant An. funestus than pyrethroid-only nets. Blood feeding rate and deterrence were significantly higher in all LLINs than control. Genotyping the L119F-GSTe2 mutation revealed that, for permethrin-based nets, 119F-GSTe2 resistant mosquitoes have a greater ability to blood feed than susceptible while the opposite effect is observed for deltamethrin-based nets. For Olyset Plus, a significant association with exophily was observed in resistant mosquitoes (OR = 11.7; p < 0.01). Furthermore, GSTe2-resistant mosquitoes (cone assays) significantly survived with PermaNet 2.0 (OR = 2.1; p < 0.01) and PermaNet 3.0 (side) (OR = 30.1; p < 0.001) but not for Olyset Plus. This study shows that the efficacy of PBO-based nets (e.g., blood feeding inhibition) against pyrethroid resistant malaria vectors could be impacted by other mechanisms including GST-mediated metabolic resistance not affected by the synergistic action of PBO. Mosaic LLINs incorporating a GST inhibitor (diethyl maleate) could help improve their efficacy in areas of GST-mediated resistance.Entities:
Keywords: Anopheles funestus; Long Lasting Insecticidal Nets; glutathione S-transferase; insecticide resistance; malaria; metabolic resistance; piperonyl butoxide
Year: 2020 PMID: 32013227 PMCID: PMC7073577 DOI: 10.3390/genes11020143
Source DB: PubMed Journal: Genes (Basel) ISSN: 2073-4425 Impact factor: 4.096
Description of the long-lasting insecticidal nets used.
| Treatment Arm | Description | Manufacturer |
|---|---|---|
|
| 100% polyester with no insecticide | Local market |
|
| 8.6 × 10−4 kg/m2 (2%) of permethrin incorporated into polyethylene | Sumitomo Chemical |
|
| 8.6 × 10−4 kg/m2 (2%) of permethrin and 4.3 × 10−4 kg/m2 (1%) of Piperonyl butoxide (PBO) incorporated into polyethylene | Sumitomo Chemical |
|
| 100% polyester coated with 1.8 g/kg of deltamethrin | Vestergaard Frandsen |
|
| Combination of 2.8 g/kg of deltamethrin coated on polyester with strengthened border (side panels) and deltamethrin (4.0 g/kg) and PBO (25 g/kg) | Vestergaard Frandsen |
Figure 1Quality control before the experimental hut trial in Mibellon: Species composition in Mibellon: (A) Quality control of the efficacy of all the four nets checked against the susceptible laboratory strain of Anopheles gambiae Ngousso and LLINs efficacy testing using cone assays against the pyrethroid resistant An. funestus population from Mibellon, Cameroon; (B) Number of mosquitoes collected during the hut effect assessment; (C) Average of Anopheles funestus. ss collected by hut during the 18 days of the hut effect investigation.
Figure 2Performance of the four LLINs in experimental hut trials against pyrethroid resistant An. funestus in Cameroon. (A) Mosquito species composition during the experimental hut study. (B) Proportion of mortality and blood feeding rate for the four LLINs against An. funestus.
Results of the performance of the five brands of LLINs against wild An. funestus females in experimental huts.
| Treatments | |||||
|---|---|---|---|---|---|
| Control | PermaNet 2.0 | PermaNet 3.0 | Olyset | Olyset Plus | |
| Females caught | 390 | 237 | 153 | 176 | 199 |
| Exophily% | 6.9 | 17.7 *** | 17.0 *** | 29.0 *** | 22.1 *** |
| 95% Confidence limits | 4.40–9.44) | (12.85–22.58) | (11.04–22.94) | (22.27–35.68) | (16.34–27.88) |
| Blood fed (%) | 40.8 | 19.8 *** | 15.7 *** | 15.3 *** | 17.2 *** |
| 95% Confidence limits | (35.89–45.65) | (14.75–24.91) | 9.92–21.45) | 10.02–20.67) | (12.74–23.44) |
| Blood feed inh. (%) | 0.0 | 51.36 | 61.52 | 62.37 | 55.63 |
| Personal protection (%) | 0.0 | 70.44 | 84.90 | 83.01 | 77.35 |
| Overall mortality (%) | 5.4 | 12.2 ** | 30.1 *** | 9.7 * | 25.1 *** |
| 95% Confidence limits | (31.14–7.62) | (8.06–16.41) | (22.80–37.33) | (5.29–14.02) | (19.10–31.15) |
| Immediate mortality | 2.6 | 5.4 | 27.6 *** | 6.1 * | 18.3 *** |
| entry rate | 33.7 | 20.5 * | 13.2 *** | 15.2 *** | 13.6 *** |
| Deterrence (%) | 0.0 | 39.2 | 60.8 | 54.9 | 49.0 |
* = p < 0.05 ** = p < 0.01 *** = p < 0.001.
Results of the performance of the four brands of LLINs against wild Mansonia spp. in experimental huts.
| Control | PermaNet 2.0 | PermaNet 3.0 | Olyset | Olyset Plus | |
|---|---|---|---|---|---|
| Total | 342 | 142 | 216 | 141 | 163 |
| Exophily% | 42.4 | 37.3 * | 31.9 ** | 28.4 ** | 31.3 ** |
| 95% Confidence limits | (37.16–47.64) | (29.37–45.28) | (25.73–38.16) | (20.93–35.81) | (24.17–38.41) |
| Blood feeding (%) | 30.1 | 16.2 ** | 9.3 *** | 15.6 *** | 20.2 ** |
| 95% Confidence limits | (25.25–34.98) | (10.14–22.26) | (5.39–13.12) | (9.61–21.59) | (14.08–26.41) |
| Blood feeding inh. (%) | 0.0 | 46.22 | 69.26 | 48.19 | 32.78 |
| Personal protection (%) | 0.0 | 77.66 | 80.53 | 78.64 | 67.96 |
| Overall mortality (%) | 37.4 | 51.4 ** | 65.5 *** | 40.4 ** | 68.1 *** |
| Immediate mortality | 36.8 | 46.5 | 62.0 *** | 39.0 *** | 65.0 *** |
| Entry rate | 34.0 | 14.1 *** | 21.5 ** | 14.0 *** | 16.2 *** |
| Deterrence (%) | 0.0 | 58.5 | 36.8 | 58.8 | 52.3 |
* = p < 0.05 ** = p < 0.01 *** = p < 0.001.
Figure 3Impact of the L119F-GSTe2 mediated metabolic resistance on bednet efficacy for blood feeding ability: (A) Genotype distribution of L119F-GSTe2 between blood fed and unfed mosquitoes after exposure to Olyset showing a significant increased ability to blood feed for resistant mosquitoes; (B) Genotype distribution of L119F-GSTe2 between blood fed and unfed mosquitoes after exposure to Olyset Plus showing a significant increased ability to blood feed for resistant; (C) Genotype distribution of L119F-GSTe2 between blood fed and unfed mosquitoes after exposure to PermaNet 2.0 showing an inverse marginal increased ability to blood feed for homozygote susceptible SS compared to homozygote resistant RR (p < 0.05); (D) Genotype distribution of L119F-GSTe2 between blood fed and unfed mosquitoes after exposure to PermaNet 3.0 showing an increased ability to blood feed of susceptible mosquitoes compared to resistant mosquitoes (R vs. S: OR = 0.29 p < 0.05).
Impact of L119F-GSTe2 mutation on the ability of various insecticide-treated nets to kill mosquitoes.
| Mortality | ||||
|---|---|---|---|---|
| Genotype | OR | PV | CI | |
|
| RR vs. SS | 0.61 | ˃0.05 | 0.22–1.66 |
| RR vs. RS | 0.59 | ˃0.05 | 0.21–1.68 | |
| RS vs. SS | 1.02 | 1 | 0.56–1.8 | |
| R vs. S | 0.85 | ˃0.05 | 0.45–1.59 | |
|
| RR vs. SS | 3.47 | ˃0.05 | 1–11.9 |
| RR vs. RS | 3.56 | ˃0.05 | 1–12.7 | |
| RS vs. SS | 0.97 | 1 | 0.53–1.76 | |
| R vs. S | 1.42 | ˃0.05 | 0.74–2.7 | |
|
| RR vs. SS | |||
| RR vs. RS | ||||
| RS vs. SS | 1.1 | 1 | 0.6 | |
| R vs. S | 1.18 | ˃0.05 | 0.6–2.2 | |
Impact of L119F-GSTe2 mutation on the efficacy of various bed nets to prevent blood feeding.
| Genotype | OR | PV | CI | |
|---|---|---|---|---|
|
| RR vs. SS | 3.3 | <0.05 | 1.19–9.2 |
| RR vs. RS | 1.07 | ˃0.05 | 0.38–3.02 | |
| RS vs. SS | 3.08 | <0.01 | 1.67–5.66 | |
| R vs. S | 2.23 | <0.05 | 1.2–4.1 | |
|
| ||||
| RR vs. SS | 12.3 | <0.001 | 2.5–60.4 | |
| RR vs. RS | 1.46 | ˃0.05 | 0.29–7.2 | |
| RS vs. SS | 8.42 | <0.001 | 4.37–16.2 | |
| R vs. S | 4.56 | <0.001 | 2.26–9.2 | |
|
| RR vs. SS | 2.6 | ˃0.05 | 0.6–11.7 |
| RR vs. RS | 0.89 | ˃0.05 | 0.2–3.9 | |
| RS vs. SS | 2.97 | <0.001 | 1.65–5.35 | |
| R vs. S | 2 | <0.05 | 1.06–3.7 | |
|
| ||||
| RS vs. SS | 3 | <0.001 | 1.67–5.4 | |
| R vs. S | 1.71 | ˃0.05 | 0.89–3.3 | |
|
| RR vs. SS | inf | ||
| RR vs. RS | inf | |||
| RS vs. SS | 0.5 | <0.05 | 0.26–0.92 | |
| R vs. S | 0.35 | <0.05 | 0.17–0.73 | |
|
| ||||
| RS vs. SS | 0.41 | ˃0.05 | 0.21–0.77 | |
| R vs. S | 0.29 | ˃0.05 | 0.14–0.63 | |
|
| RR vs. SS | 0.4 | ˃0.05 | 0.1–1.56 |
| RR vs. RS | 0.48 | ˃0.05 | 0.12–1.9 | |
| RS vs. SS | 0.8 | ˃0.05 | 0.47–1.5 | |
| R vs. S | 1.31 | ˃0.05 | 0.6–2.5 | |
Figure 4Impact of the L119F-GSTe2 mediated metabolic resistance on bednet efficacy -exophily: (A) Genotype distribution of L119F-GSTe2 between indoor (Room) and outdoor (verandah) mosquitoes after exposure to Olyset showing no association; (B) Genotype distribution of L119F-GSTe2 between indoor (Room) and outdoor (verandah) mosquitoes after exposure to Olyset Plus showing a significant increased ability to exit the room when considering all mosquitoes; (C) A greater association is observed with exophily with Olyset Plus when only analyzing unfed mosquitoes; (D) Genotype distribution of L119F-GSTe2 between indoor (Room) and outdoor (verandah) mosquitoes after exposure to PermaNet 2.0 showing a significant association (RS vs. SS: OR = 1.35; p < 0.01); (E) Genotype distribution of L119F-GSTe2 between indoor (Room) and outdoor (verandah) mosquitoes after exposure to PermaNet 3.0 showing no association.
Impact of L119F-GSTe2 mutation on the efficacy of various bed nets in repellency.
| Exophily | ||||
|---|---|---|---|---|
| Genotype | OR | PV | CI | |
|
| RR vs. SS | 3.1 | ˃0.05 | 1.1–9 |
| RR vs. RS | 2.48 | ˃0.05 | 0.83–7.42 | |
| RS vs. SS | 1.25 | ˃0.05 | 0.67–2.26 | |
| R vs. S | 1.1 | ˃0.05 | 0.6–2.2 | |
|
| ||||
| RR vs. SS | 11.76 | <0.01 | 2.59–53.4 | |
| RR vs. RS | 3.9 | 1 | 0.8–18.59 | |
| RS vs. SS | 2.99 | <0.01 | 1.58–5.6 | |
| R vs. S | 3.4 | <0.001 | 1.67–6.9 | |
| RS vs. SS | 1.18 | ˃0.05 | 0.6–2.1 | |
| R vs. S | 1.17 | ˃0.05 | 0.62–2.2 | |
|
| RR vs. SS | 1.22 | 1 | 0.46–3.2 |
| RR vs. RS | 1.68 | ˃0.05 | 0.6–4.7 | |
| RS vs. SS | 0.59 | ˃0.05 | 0.31–1.12 | |
| R vs. S | 0.94 | 1 | 0.5–1.8 | |
|
| RS vs. SS | 1.35 | <0.01 | 0.75–2.43 |
| R vs. S | 1.22 | ˃0.05 | 0.65–2.3 | |
|
| ||||
| RS vs. SS | 3.37 | <0.001 | 1.84–6.17 | |
| R vs. S | 1.8 | ˃0.05 | 0.99–3.38 | |
Figure 5Association between L119F-GSTe2 mutation and ability to survive exposure to LLINs (cone assays) and WHO papers (bioassays): (A) Genotype distribution of L119F-GSTe2 between alive and dead mosquitoes after exposure to Olyset Plus showing no association; (B) Genotype distribution of L119F-GSTe2 between alive and dead mosquitoes after exposure to PermaNet 2.0 showing a significantly increased ability of resistant mosquitoes to survive (R vs. S: p < 0.01); (C) Genotype distribution of L119F-GSTe2 between alive and dead mosquitoes after exposure to PermaNet 3.0 showing a significantly greater ability of resistant mosquitoes to survive than that seen for PermaNet 2.0 (RR vs. SS: OR = 30.1; p < 0.001); (D) Genotype distribution of L119F-GSTe2 between alive (90 min) and dead (30 min) mosquitoes after exposure to deltamethrin showing a significantly greater ability of homozygote resistant mosquitoes to survive (RR vs. SS: OR = 4.6; p < 0.001); (E) Similarly for permethrin, homozygote resistant mosquitoes exhibit a significantly greater ability of to survive (RR vs. SS: OR = 4.8; p < 0.001); (F) For DDT, a much greater ability of mosquitoes with the resistance allele to survive exposure to DDT papers (RR vs. SS: OR = 66.7; p < 0.001).
Impact of GSTe2 on the ability of field population An. funestus to survive using samples from cone assays.
|
| ||||
|
|
|
| ||
| RR vs. SS | 1.1 | ˃0.05 | 0.4–2.7 | |
| RS vs. SS | 0.9 | 1.0 | 0.5–1.8 | |
| RR vs. RS | 1.1 | ˃0.05 | 0.4–2.7 | |
| R vs. S | 1.04 | 1.0 | 0.5–1.8 | |
| RR vs. SS | 2.09 | <0.01 | 1.1–4.2 | |
| RS vs. SS | 2.3 | <0.001 | 1.2–4.4 | |
| RR vs. RS | 0.8 | ˃0.05 | 0.3–2.4 | |
| R vs. S | 1.8 | <0.01 | 0.9–3.5 | |
| RR vs. SS | 30.1 | <0.001 | 0.8–5.3 | |
| RS vs. SS | 2.4 | <0.01 | 1.3–4.5 | |
| RR vs. RS | 12.3 | <0.001 | 1.5–98.6 | |
| R vs. S | 3.8 | <0.001 | 1.8–7.7 | |
|
| ||||
|
|
|
| ||
| RR vs. SS | 4.6 | <0.001 | 2.5–8.4 | |
| RS vs. SS | 1.22 | ˃0.05 | 0.69–2.15 | |
| RR vs. RS | 3.75 | <0.001 | 2.1–6.8 | |
| R vs. S | 2.80 | <0.01 | 1.54–5.1 | |
| RR vs. SS | 4.8 | <0.001 | 2.66–8.8 | |
| RS vs. SS | 1.6 | ˃0.05 | 0.86–2.8 | |
| RR vs. RS | 3.1 | <0.001 | 1.7–5.5 | |
| R vs. S | 2.99 | <0.001 | 1.7–5.3 | |
| RR vs. SS | 66.7 | <0.001 | 27.1–164 | |
| RS vs. SS | 14.0 | <0.001 | 6.3–31.2 | |
| RR vs. RS | 4.8 | <0.001 | 2.4–9.5 | |
| R v S | 15.3 | <0.001 | 7.7–30.5 | |
OR, Odds ratio; PV, p value; CI, Confidence interval.